Myelos Corporation avientpharma.com


Public lists: Pharma Startups (4732)

Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical products that target unmet medical needs in rheumatology and other specialty niche medical markets. The company's focus is on the company's biologic product candidate, Puricase (pegloticase) that has been developed for treatment-failure gout (TFG).

Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical products that target unmet medical needs in rheumatology and other specialty niche medical markets. The company's focus is on t...Show all

Company (Alive / Active)

Phone: 858-657-1040

Fax:

4940 Carroll Canyon Road
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Myelos Corporation $0M Nov 30, 2018
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Myelos Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Competitors

Company Status Description Investors

Epix Pharmaceuticals

Lexington, Massachusetts, United States
Dead / InactiveEPIX Pharmaceuticals, formed from the merger of Predix Pharmaceuticals and Epix Pharmaceuticals, is a biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products through the use of technology to better diagnose, treat and manage patients.Login to see details

OraPharma

Horsham, Pennsylvania, United States
AcquiredOraPharma is a specialty pharmaceutical company that develops and commercializes products that improve and maintain oral health. The company is dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices. OraPharma's lead product, ARESTIN (minocycline hydrochloride), is a locally administered antibiotic for the treatment of periodontitis that utilizes an advanced controlled-release delivery system. In February 2003, OraPharma was acqu...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Retro-inverso peptides derived from interleukin-6 Mar 31, 2010 Nov 22, 2011 Patent
Methods of using retro-inverso peptides derived from interleukin-6 Oct 05, 2006 Jul 13, 2010 Patent
Method of using retro inverso peptides derived from leukemia inhibitory factor Aug 09, 2006 Jul 13, 2010 Patent
Prosaposin as a neurotrophic factor Jun 18, 2003 Apr 28, 2009 Patent